Cargando…

Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum

BACKGROUND: Antibody responses to malaria antigens reflect exposure to parasites, and seroprevalence correlates with malaria transmission intensity. Antibodies are routinely measured in sera or on dried blood spots but a non-invasive method would provide extra utility in sampling general populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Estévez, Patricia Tabernero, Satoguina, Judith, Nwakanma, Davis C, West, Sheila, Conway, David J, Drakeley, Chris J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112448/
https://www.ncbi.nlm.nih.gov/pubmed/21527045
http://dx.doi.org/10.1186/1475-2875-10-104
_version_ 1782205750570909696
author Estévez, Patricia Tabernero
Satoguina, Judith
Nwakanma, Davis C
West, Sheila
Conway, David J
Drakeley, Chris J
author_facet Estévez, Patricia Tabernero
Satoguina, Judith
Nwakanma, Davis C
West, Sheila
Conway, David J
Drakeley, Chris J
author_sort Estévez, Patricia Tabernero
collection PubMed
description BACKGROUND: Antibody responses to malaria antigens reflect exposure to parasites, and seroprevalence correlates with malaria transmission intensity. Antibodies are routinely measured in sera or on dried blood spots but a non-invasive method would provide extra utility in sampling general populations. Saliva is already in use in the detection of plasma-derived IgM and IgG to viral infections. In this study, antibodies to Plasmodium falciparum merozoite antigens were compared between blood and saliva samples from the same individuals in unlinked surveys conducted in Tanzania and The Gambia. METHODS: In Tanzania, 53 individuals provided paired fingerprick blood and saliva sample using two commercially available sampling devices. In the Gambia, archived plasma and saliva samples collected from 200 children in the Farafenni area in a cross-sectional survey were analyzed. IgG antibodies against P. falciparum antigens, Merozoite Surface Protein-1 (MSP-1(19)) and Apical membrane Antigen (AMA-1) were measured by ELISA in paired saliva and blood samples from both sites. Antibody levels were compared as continuous optical density (OD) values and by sero-positivity. RESULTS: Significant correlations between saliva and plasma antibody levels were seen in Tanzania for both antigens, AMA-1(r(2 )range 0.93 to 0.89, p < 0.001) and MSP-1(19 )(r(2 )range 0.93 to 0.75, p < 0.001), with a weaker correlation for results from The Gambia (r(2)range 0.64 to 0.63, p < 0.01). When assessed as seropositivity and compared with plasma, sensitivity and specificity were good with saliva antibody levels to both AMA-1 and MSP-1(19 )(sensitivity range 64-77% and specificity range 91-100% & 47-67% and 90-97% respectively) over the different sample sets. CONCLUSIONS: These data demonstrate anti-malarial antibodies can be detected in saliva and correlate strongly with levels in plasma. This non-invasive relatively simple collection method will be potentially useful for general population surveys, and particularly in migratory populations or those with infrequent contact with health services or opposed to blood withdrawal. Further studies will be needed to optimize collection methods, standardize volumes and content and develop controls.
format Online
Article
Text
id pubmed-3112448
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31124482011-06-12 Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum Estévez, Patricia Tabernero Satoguina, Judith Nwakanma, Davis C West, Sheila Conway, David J Drakeley, Chris J Malar J Research BACKGROUND: Antibody responses to malaria antigens reflect exposure to parasites, and seroprevalence correlates with malaria transmission intensity. Antibodies are routinely measured in sera or on dried blood spots but a non-invasive method would provide extra utility in sampling general populations. Saliva is already in use in the detection of plasma-derived IgM and IgG to viral infections. In this study, antibodies to Plasmodium falciparum merozoite antigens were compared between blood and saliva samples from the same individuals in unlinked surveys conducted in Tanzania and The Gambia. METHODS: In Tanzania, 53 individuals provided paired fingerprick blood and saliva sample using two commercially available sampling devices. In the Gambia, archived plasma and saliva samples collected from 200 children in the Farafenni area in a cross-sectional survey were analyzed. IgG antibodies against P. falciparum antigens, Merozoite Surface Protein-1 (MSP-1(19)) and Apical membrane Antigen (AMA-1) were measured by ELISA in paired saliva and blood samples from both sites. Antibody levels were compared as continuous optical density (OD) values and by sero-positivity. RESULTS: Significant correlations between saliva and plasma antibody levels were seen in Tanzania for both antigens, AMA-1(r(2 )range 0.93 to 0.89, p < 0.001) and MSP-1(19 )(r(2 )range 0.93 to 0.75, p < 0.001), with a weaker correlation for results from The Gambia (r(2)range 0.64 to 0.63, p < 0.01). When assessed as seropositivity and compared with plasma, sensitivity and specificity were good with saliva antibody levels to both AMA-1 and MSP-1(19 )(sensitivity range 64-77% and specificity range 91-100% & 47-67% and 90-97% respectively) over the different sample sets. CONCLUSIONS: These data demonstrate anti-malarial antibodies can be detected in saliva and correlate strongly with levels in plasma. This non-invasive relatively simple collection method will be potentially useful for general population surveys, and particularly in migratory populations or those with infrequent contact with health services or opposed to blood withdrawal. Further studies will be needed to optimize collection methods, standardize volumes and content and develop controls. BioMed Central 2011-04-29 /pmc/articles/PMC3112448/ /pubmed/21527045 http://dx.doi.org/10.1186/1475-2875-10-104 Text en Copyright ©2011 Estévez et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Estévez, Patricia Tabernero
Satoguina, Judith
Nwakanma, Davis C
West, Sheila
Conway, David J
Drakeley, Chris J
Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum
title Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum
title_full Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum
title_fullStr Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum
title_full_unstemmed Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum
title_short Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum
title_sort human saliva as a source of anti-malarial antibodies to examine population exposure to plasmodium falciparum
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112448/
https://www.ncbi.nlm.nih.gov/pubmed/21527045
http://dx.doi.org/10.1186/1475-2875-10-104
work_keys_str_mv AT estevezpatriciatabernero humansalivaasasourceofantimalarialantibodiestoexaminepopulationexposuretoplasmodiumfalciparum
AT satoguinajudith humansalivaasasourceofantimalarialantibodiestoexaminepopulationexposuretoplasmodiumfalciparum
AT nwakanmadavisc humansalivaasasourceofantimalarialantibodiestoexaminepopulationexposuretoplasmodiumfalciparum
AT westsheila humansalivaasasourceofantimalarialantibodiestoexaminepopulationexposuretoplasmodiumfalciparum
AT conwaydavidj humansalivaasasourceofantimalarialantibodiestoexaminepopulationexposuretoplasmodiumfalciparum
AT drakeleychrisj humansalivaasasourceofantimalarialantibodiestoexaminepopulationexposuretoplasmodiumfalciparum